搜索结果81-90 的 849 / anti-TNF drugs

  1. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

  2. Mayo Clinic Physician Update - June 2023

    Page 1.

  3. GLP-1 激动剂：糖尿病药物和减重- 妙佑医疗国际

    Dungan K, et al. Glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus. https://www.uptodate.com/contents/search. Accessed ...

  4. 放射科- 临床试验- 妙佑医疗国际

    ... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...

  5. 肾病和高血压- 临床试验- 妙佑医疗国际

    Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD. ... treatment and errors will be caught and corrected by ...

  6. 精神病科和心理科- 妙佑医疗国际 - 临床试验

    The purpose of this study is to assess the feasibility, acceptability, usability, and preliminary outcomes of a treatment protocol (FBT-PC) for PCP ...

  7. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  8. 神经科- 临床试验- 妙佑医疗国际

    To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

  9. 传染病- 临床试验- 妙佑医疗国际

    ... treatment variations, as well as the factors that ... The third aim is to measure SARS-CoV-2 anti-spike and anti ... treatment variations, as well as the ...

  10. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...